Ifp Advisors, Inc Sutro Biopharma, Inc. Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 78 shares of STRO stock, worth $63. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$63

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 24, 2025	BUY	$0.52 - $1.3 $40 - $101	78 New	78 $0
Q4 2024 Feb 04, 2025	BUY	$1.82 - $4.4 $54 - $132	30 New	30 $0

Others Institutions Holding STRO

# of Institutions

102

Shares Held

58.5M

Call Options Held

92.8K

Put Options Held

Black Rock Inc. New York, NY

6.91M
Shares

$5.6 Million
0.0% of portfolio
Suvretta Capital Management, LLC New York, NY

6.49M
Shares

$5.26 Million
0.16% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.09M
Shares

$4.12 Million
0.43% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.73M
Shares

$3.83 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.68M
Shares

$2.98 Million
0.0% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $42.3M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account